These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 39232419)
21. Addressing recent challenges in isotope ratio mass spectrometry: Development of a method applicable to 1-androstene-steroids, 6α-hydroxy-androstenedione, and androstatrienedione. Piper T; Thevis M Drug Test Anal; 2022 Nov; 14(11-12):1891-1903. PubMed ID: 36001066 [TBL] [Abstract][Full Text] [Related]
22. Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS. Aguilera R; Chapman TE; Pereira H; Oliveira GC; Illanes RP; Fernandes TF; Azevedo DA; Neto FA J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):107-14. PubMed ID: 19428237 [TBL] [Abstract][Full Text] [Related]
23. Development of an analytical method for the determination of the misuse in sports of boldenone through the analysis of urine by on-line coupling liquid chromatography-gas chromatography-combustion-isotope ratio mass spectrometry. Toledano RM; Díaz-Plaza EM; Cortes JM; Aragón A; Vázquez AM; Villén J; Muñoz-Guerra J J Chromatogr A; 2014 Nov; 1370():171-8. PubMed ID: 25454142 [TBL] [Abstract][Full Text] [Related]
24. Urinary concentrations of AICAR and mannitol in athlete population. Sobolevsky T; Ahrens B Drug Test Anal; 2019 Mar; 11(3):530-535. PubMed ID: 30548818 [TBL] [Abstract][Full Text] [Related]
25. External calibration in gas chromatography-combustion-isotope ratio mass spectrometry measurements of endogenous androgenic anabolic steroids in sports doping control. Kioussi MK; Angelis YS; Cawley AT; Koupparis M; Kazlauskas R; Brenna JT; Georgakopoulos CG J Chromatogr A; 2011 Aug; 1218(33):5675-82. PubMed ID: 21752385 [TBL] [Abstract][Full Text] [Related]
26. GC-C-IRMS in routine doping control practice: 3 years of drug testing data, quality control and evolution of the method. Polet M; Van Eenoo P Anal Bioanal Chem; 2015 Jun; 407(15):4397-409. PubMed ID: 25503937 [TBL] [Abstract][Full Text] [Related]
27. Doping control analysis of 46 polar drugs in horse plasma and urine using a 'dilute-and-shoot' ultra high performance liquid chromatography-high resolution mass spectrometry approach. Kwok WH; Choi TLS; Kwok KY; Chan GHM; Wong JKY; Wan TSM J Chromatogr A; 2016 Jun; 1451():41-49. PubMed ID: 27180888 [TBL] [Abstract][Full Text] [Related]
28. Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control. Brooker L; Parr MK; Cawley A; Flenker U; Howe C; Kazlauskas R; Schänzer W; George A Drug Test Anal; 2009 Nov; 1(11-12):587-95. PubMed ID: 20355175 [TBL] [Abstract][Full Text] [Related]
29. Detection of synthetic testosterone use by novel comprehensive two-dimensional gas chromatography combustion-isotope ratio mass spectrometry. Tobias HJ; Zhang Y; Auchus RJ; Brenna JT Anal Chem; 2011 Sep; 83(18):7158-65. PubMed ID: 21846122 [TBL] [Abstract][Full Text] [Related]
30. Development of a GC/C/IRMS method--confirmation of a novel steroid profiling approach in doping control. Van Renterghem P; Polet M; Brooker L; Van Gansbeke W; Van Eenoo P Steroids; 2012 Sep; 77(11):1050-60. PubMed ID: 22728892 [TBL] [Abstract][Full Text] [Related]
31. Detecting the abuse of 19-norsteroids in doping controls: A new gas chromatography coupled to isotope ratio mass spectrometry method for the analysis of 19-norandrosterone and 19-noretiocholanolone. Iannella L; Colamonici C; Curcio D; Botrè F; de la Torre X Drug Test Anal; 2021 Apr; 13(4):770-784. PubMed ID: 33242373 [TBL] [Abstract][Full Text] [Related]
32. Detection of formestane abuse by mass spectrometric techniques. de la Torre X; Colamonici C; Curcio D; Jardines D; Molaioni F; Parr MK; Botrè F Drug Test Anal; 2014; 6(11-12):1133-40. PubMed ID: 25516450 [TBL] [Abstract][Full Text] [Related]
33. Optimization of an online heart-cutting multidimensional gas chromatography clean-up step for isotopic ratio mass spectrometry and simultaneous quadrupole mass spectrometry measurements of endogenous anabolic steroid in urine. Casilli A; Piper T; de Oliveira FA; Padilha MC; Pereira HM; Thevis M; de Aquino Neto FR Drug Test Anal; 2016 Nov; 8(11-12):1204-1211. PubMed ID: 27739243 [TBL] [Abstract][Full Text] [Related]
34. The application of carbon isotope ratio mass spectrometry to doping control. Cawley AT; Flenker U J Mass Spectrom; 2008 Jul; 43(7):854-64. PubMed ID: 18523972 [TBL] [Abstract][Full Text] [Related]
35. New potential markers for the detection of boldenone misuse. Gómez C; Pozo OJ; Geyer H; Marcos J; Thevis M; Schänzer W; Segura J; Ventura R J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):239-46. PubMed ID: 22664392 [TBL] [Abstract][Full Text] [Related]
36. Detection of dehydroepiandrosterone misuse by means of gas chromatography- combustion-isotope ratio mass spectrometry. Mareck U; Geyer H; Flenker U; Piper T; Thevis M; Schänzer W Eur J Mass Spectrom (Chichester); 2007; 13(6):419-26. PubMed ID: 18417762 [TBL] [Abstract][Full Text] [Related]
37. High-temperature liquid chromatography-isotope ratio mass spectrometry methodology for carbon isotope ratio determination of anabolic steroids in urine. Honesova L; Viaene W; Van Eenoo P; Polet M Anal Chim Acta; 2024 Oct; 1324():343092. PubMed ID: 39218574 [TBL] [Abstract][Full Text] [Related]
38. Isotope ratio mass spectrometry in antidoping analysis: The use of endogenous reference compounds. de la Torre X; Jardines D; Curcio D; Colamonici C; Botrè F Rapid Commun Mass Spectrom; 2019 Mar; 33(6):579-586. PubMed ID: 30589473 [TBL] [Abstract][Full Text] [Related]
39. Metabolism of boldione in humans by mass spectrometric techniques: detection of pseudoendogenous metabolites. de la Torre X; Curcio D; Colamonici C; Molaioni F; Botrè F Drug Test Anal; 2013; 5(11-12):834-42. PubMed ID: 24259377 [TBL] [Abstract][Full Text] [Related]
40. Carbon isotopic characterization of prednisolone and prednisone pharmaceutical formulations: Implications in antidoping analysis. Iannella L; Botrè F; Colamonici C; Curcio D; Ciccarelli C; Mazzarino M; de la Torre X Drug Test Anal; 2020 Nov; 12(11-12):1587-1598. PubMed ID: 32529794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]